A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand

Introduction: Esketamine has been approved in Australia and New Zealand as a third-line antidepressant treatment for treatment resistant depression. This study describes changes in quality of life, depressive symptoms and productivity in participants treated with esketamine in real-world settings. M...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Malcolm Hopwood, Elizabeth M. Scott, David Codyre, David Barton, Andrea Puig, Jarrad King, Gero Joks, Ian B. Hickie
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2024-09-01
Cyfres:	Psychiatry Research Communications
Pynciau:	Depressive disorder Major Esketamine Quality of life Real-world Australia and New Zealand
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2772598724000230
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!